<DOC>
	<DOCNO>NCT01469325</DOCNO>
	<brief_summary>Sequential leave prefrontal Repetitive Transcranial Magnetic Stimulation ( rTMS ) , high frequency , Treatment-Resistant Depression show antidepressant effect . doubt remain magnitude previously demonstrate treatment effects.The aim study To test whether daily weekday leave prefrontal rTMS safely effectively treat Resistant Depression disorder compare sham control .</brief_summary>
	<brief_title>Sequential Left Prefrontal Repetitive Transcranial Magnetic Stimulation , With High Frequency , Treatment-Resistant Depression</brief_title>
	<detailed_description>Design : Prospective , randomize , active sham-controlled ( 1:1 randomization ) , duration-adaptive design 3 week daily weekday treatment ( fixed-dose phase ) follow continue blind treatment another 3 week improver . Setting : University psychiatric hospital Tehran include Roozbeh Hospital , Rasool Hospital Imam Hossein General Hospital refer client Iranian National Center Addiction Studies , Tehran University Medical Sciences . Patients : About 60 patient unipolar nonpsychotic major depressive disorder , accord DSM-IV , resistant treatment . INTERVENTION : We deliver rTMS leave prefrontal cortex 120 % motor threshold ( 10 Hz , 4-second train duration , 26-second intertrain interval ) 37.5 minute ( 3000 pulse per session ) use figure-eight solid-core coil . Sham rTMS use similar coil metal insert block magnetic field scalp electrode deliver matched somatosensory sensation .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Treatment-Resistant</mesh_term>
	<criteria>DSMIV diagnosis major depression Resistance treatment define insufficient clinical benefit least one adequate medication trial Other current Axis I disorder ( except simple phobia nicotine addiction ) Personal close family history seizure disorder Ferromagnetic material body close head Neurologic disorder Pregnancy Taking medication know low seizure threshold ( eg , theophylline )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Repetitive Transcranial Magnetic Stimulation</keyword>
	<keyword>Depression</keyword>
	<keyword>leave prefrontal</keyword>
</DOC>